 Elanco Animal Health Incorporated NYSE: ELAN and Ginkgo Bioworks Holdings Inc NYSE: DNA have launched BiomEdit, a microbiome innovation company. BiomEdit will discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines, and. 